Fresenius Medical Care AG
This article was originally published in The Gray Sheet
Executive Summary
German dialysis product and service provider is "considering various financing options, mainly for further dialysis clinic acquisitions worldwide," according to a June 20 release. The operator of approximately 1,100 dialysis clinics in North America, Europe, Latin America and the Asia-Pacific region currently, Fresenius says it "has asked a banking consortium to investigate the placement of new preference shares to finance possible acquisitions." On June 23, the firm completed its acquisition of the 87 clinic facilities that make up the international and non-continental U.S. operations of DaVita, formerly known as Total Renal Care Holdings, for $145 mil., including $3 mil. in debt. A definitive agreement had been signed in January. Fresenius says it "will continue to pursue clinic acquisitions on a global basis that are financially accretive and located in markets that the company regards as strategically important"
You may also be interested in...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.